The document discusses emerging technologies and horizon scanning for new medicines by the Scottish Medicines Consortium. It involves continuously tracking new medicines, analyzing clinical and epidemiological data including Scotland-specific data from various sources, and getting expert advice from NHS Scotland clinicians. Potential new medicines are filtered and selected based on their relevance and impact, both financially and for services. Product monographs are developed with estimated uptake and budget impacts. The annual Forward Look report is the output of this process.